| http://www.w3.org/ns/prov#value | - ???The transaction to license and acquire these products is a key first step in achieving our objective of building a leading specialty pharmaceutical company,??? added GTCR Principal, Dean Mihas. ???The Actient management team led by Ed Fiorentino has an impressive track record of establishing and growing businesses and we???re excited to be a partner in this transaction and are committed to prov
|
